Physicians, patients, and families rely on clinical factors associated with stroke mortality to
guide decisions of care and set goals of medical therapy. However, these factors, including …

B-type natriuretic peptide (BNP), along with an inactive N-terminal peptide fragment (NT-
proBNP), is secreted by cardiac ventricular myocytes in response to excessive myocardial …

such as left ventricular ejection fraction and left atrium diameter. A stroke neurologist,
blinded to the BNP data, assigned each patient a stroke subtype according to Trial of ORG …

Background and Purpose—Elevated serum levels of brain natriuretic peptide (BNP) have
been associated with cardioembolic stroke and increased poststroke mortality. We sought to …

Objective: To measure the association of B-type natriuretic peptide (BNP) and N-terminal
fragment of BNP (NT-proBNP) with all-cause mortality after stroke, and to evaluate the …

BACKGROUND and OBJECTIVE: Although previous studies have shown brain natriuretic
peptide (BNP) level was useful for a diagnosis of the subtype in ischemic stroke, only a few …

We read with interest the article by Zeynep Cakir and colleagues on brain natriuretic peptide
(BNP) in stroke or hypertension patients,[1] and wish to share a few opinions about the use …

Functional outcome after cardiovascular and cerebrovascular events is traditionally
predicted using demographic and clinical variables like age, gender, blood pressure …

Background: At the present time, the determination of the outcome of stroke patients is
based on the analysis of clinical and neuroimaging data. The use of prognostic blood …

OBJECTIVE: To investigate the relationship of N-terminal pro-BNP (NT-proBNP) with each
cardioembolic source, functional outcome, short-/long-term mortality, and stroke recurrence …